Christine Ring, Chief Legal Officer at Nurix Therapeutics ($NRIX), sold about $1.34 million worth of company shares across 11 open market transactions over the past year. Her most recent sale occurred on March 2, 2026. These sales rank her 4,273rd among 11,678 insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 8148 | $15.24 | 26,453.0000 | 102,843,012 | 23.55% | 0.01% |
| March 2, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 8148 | $15.44 | 34,601.0000 | 102,843,012 | 19.06% | 0.01% |
| Feb. 10, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | A | Employee Stock Option (right to buy) | 93750 | $0.00 | 93,750.0000 | 102,843,012 | 9999.99% | 0.09% |
| Feb. 10, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | A | Restricted Stock Units | 42875 | $0.00 | 42,875.0000 | 102,843,012 | 9999.99% | 0.04% |
| Feb. 9, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 14261 | $16.66 | 42,749.0000 | 102,843,012 | 25.01% | 0.01% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 54,822.0000 | 102,843,012 | 3.79% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 58,572.0000 | 102,843,012 | 6.84% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2859 | $0.00 | 61,431.0000 | 102,843,012 | 4.88% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 4333 | $16.58 | 57,098.0000 | 102,843,012 | 7.05% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 88 | $17.37 | 57,010.0000 | 102,843,012 | 0.15% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1925 | $0.00 | 0.0000 | 102,843,012 | 100.00% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 2,000.0000 | 102,843,012 | 50.00% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 18,750.0000 | 102,843,012 | 16.67% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2859 | $0.00 | 25,725.0000 | 102,843,012 | 10.00% | 0.00% |
| Jan. 30, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1925 | $0.00 | 52,822.0000 | 102,843,012 | 3.78% | 0.00% |
| Jan. 20, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3760 | $1.86 | 54,657.0000 | 76,883,436 | 7.39% | 0.00% |
| Jan. 20, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 3760 | $0.00 | 8,643.0000 | 76,883,436 | 30.32% | 0.00% |
| Jan. 20, 2026 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 3760 | $18.42 | 50,897.0000 | 76,883,436 | 6.88% | 0.00% |
| Dec. 18, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3760 | $1.86 | 54,657.0000 | 76,883,436 | 7.39% | 0.00% |
| Dec. 18, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 3760 | $0.00 | 12,403.0000 | 76,883,436 | 23.26% | 0.00% |
| Dec. 18, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 200 | $18.56 | 50,897.0000 | 76,883,436 | 0.39% | 0.00% |
| Dec. 18, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 3560 | $17.87 | 51,097.0000 | 76,883,436 | 6.51% | 0.00% |
| Nov. 24, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 37600 | $1.86 | 88,497.0000 | 76,883,436 | 73.87% | 0.05% |
| Nov. 24, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 37600 | $17.07 | 50,897.0000 | 76,883,436 | 42.49% | 0.05% |
| Nov. 24, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 37600 | $0.00 | 16,163.0000 | 76,883,436 | 69.94% | 0.05% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 45,933.0000 | 76,883,436 | 4.37% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 47,933.0000 | 76,883,436 | 4.35% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 51,683.0000 | 76,883,436 | 7.82% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 1,925.0000 | 76,883,436 | 49.99% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 4,000.0000 | 76,883,436 | 33.33% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 22,500.0000 | 76,883,436 | 14.29% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2858 | $0.00 | 28,584.0000 | 76,883,436 | 9.09% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 3644 | $12.80 | 50,897.0000 | 76,883,436 | 6.68% | 0.00% |
| Oct. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2858 | $0.00 | 54,541.0000 | 76,883,436 | 5.53% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2858 | $0.00 | 47,850.0000 | 75,886,817 | 6.35% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 3,849.0000 | 75,886,817 | 33.33% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 41,242.0000 | 75,886,817 | 5.10% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2858 | $0.00 | 31,442.0000 | 75,886,817 | 8.33% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 26,250.0000 | 75,886,817 | 12.50% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 6,000.0000 | 75,886,817 | 25.00% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 44,992.0000 | 75,886,817 | 9.09% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 39,242.0000 | 75,886,817 | 5.16% | 0.00% |
| July 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 3841 | $12.01 | 44,009.0000 | 75,886,817 | 8.03% | 0.01% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 2894 | $11.50 | 37,318.0000 | 75,886,817 | 7.20% | 0.00% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 5,773.0000 | 75,886,817 | 25.00% | 0.00% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 8,000.0000 | 75,886,817 | 20.00% | 0.00% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 30,000.0000 | 75,886,817 | 11.11% | 0.00% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 36,462.0000 | 75,886,817 | 5.80% | 0.00% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 40,212.0000 | 75,886,817 | 10.28% | 0.00% |
| April 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 34,462.0000 | 75,886,817 | 5.91% | 0.00% |
| Feb. 11, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 75,886,817 | 9999.99% | 0.10% |
| Feb. 11, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | A | Restricted Stock Units | 34300 | $0.00 | 34,300.0000 | 75,886,817 | 9999.99% | 0.05% |
| Jan. 31, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 5660 | $19.94 | 32,638.0000 | 75,886,817 | 14.78% | 0.01% |
| Jan. 31, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 223 | $1.86 | 32,761.0000 | 75,886,817 | 0.69% | 0.00% |
| Jan. 31, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5537 | $1.86 | 38,298.0000 | 75,886,817 | 16.90% | 0.01% |
| Jan. 31, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 100 | $20.48 | 32,538.0000 | 75,886,817 | 0.31% | 0.00% |
| Jan. 31, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 223 | $0.00 | 53,763.0000 | 75,886,817 | 0.41% | 0.00% |
| Jan. 31, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5537 | $0.00 | 0.0000 | 75,886,817 | 100.00% | 0.01% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 7,697.0000 | 75,886,817 | 20.00% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 33,750.0000 | 75,886,817 | 10.00% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 10,000.0000 | 75,886,817 | 16.67% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 30,008.0000 | 75,886,817 | 6.85% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 32,008.0000 | 75,886,817 | 6.66% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 35,758.0000 | 75,886,817 | 11.72% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 2929 | $19.81 | 32,829.0000 | 75,886,817 | 8.19% | 0.00% |
| Jan. 30, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 291 | $20.33 | 32,538.0000 | 75,886,817 | 0.89% | 0.00% |
| Jan. 2, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 5760 | $19.50 | 28,084.0000 | 67,120,266 | 17.02% | 0.01% |
| Jan. 2, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 33,844.0000 | 67,120,266 | 20.51% | 0.01% |
| Jan. 2, 2025 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 53,986.0000 | 67,120,266 | 9.64% | 0.01% |
| Dec. 2, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 5760 | $21.73 | 28,084.0000 | 67,120,266 | 17.02% | 0.01% |
| Dec. 2, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 33,844.0000 | 67,120,266 | 20.51% | 0.01% |
| Dec. 2, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 59,746.0000 | 67,120,266 | 8.79% | 0.01% |
| Nov. 4, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 3290 | $0.00 | 96,389.0000 | 72,779,381 | 3.30% | 0.00% |
| Nov. 4, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 3290 | $25.00 | 28,084.0000 | 72,779,381 | 10.49% | 0.00% |
| Nov. 4, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3290 | $9.57 | 31,374.0000 | 72,779,381 | 11.71% | 0.00% |
| Nov. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 5760 | $24.28 | 28,084.0000 | 72,779,381 | 17.02% | 0.01% |
| Nov. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 33,844.0000 | 72,779,381 | 20.51% | 0.01% |
| Nov. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 65,506.0000 | 72,779,381 | 8.08% | 0.01% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 9,621.0000 | 72,779,381 | 16.67% | 0.00% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 26,516.0000 | 72,779,381 | 7.82% | 0.00% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 28,516.0000 | 72,779,381 | 7.54% | 0.00% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 32,266.0000 | 72,779,381 | 13.15% | 0.01% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 4182 | $24.31 | 28,084.0000 | 72,779,381 | 12.96% | 0.01% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 12,000.0000 | 72,779,381 | 14.29% | 0.00% |
| Oct. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 37,500.0000 | 72,779,381 | 9.09% | 0.01% |
| Oct. 14, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 3290 | $0.00 | 99,679.0000 | 72,779,381 | 3.20% | 0.00% |
| Oct. 14, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 3290 | $25.00 | 24,592.0000 | 72,779,381 | 11.80% | 0.00% |
| Oct. 14, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3290 | $9.57 | 27,882.0000 | 72,779,381 | 13.38% | 0.00% |
| Oct. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 5460 | $22.19 | 24,892.0000 | 72,779,381 | 17.99% | 0.01% |
| Oct. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 300 | $22.81 | 24,592.0000 | 72,779,381 | 1.21% | 0.00% |
| Oct. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 30,352.0000 | 72,779,381 | 23.42% | 0.01% |
| Oct. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 71,266.0000 | 72,779,381 | 7.48% | 0.01% |
| Sept. 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 200 | $25.62 | 24,592.0000 | 72,779,381 | 0.81% | 0.00% |
| Sept. 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 30,352.0000 | 72,779,381 | 23.42% | 0.01% |
| Sept. 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3290 | $9.57 | 33,642.0000 | 72,779,381 | 10.84% | 0.00% |
| Sept. 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 3290 | $0.00 | 102,969.0000 | 72,779,381 | 3.10% | 0.00% |
| Sept. 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 77,026.0000 | 72,779,381 | 6.96% | 0.01% |
| Sept. 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 8850 | $24.93 | 24,792.0000 | 72,779,381 | 26.31% | 0.01% |
| Aug. 26, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 4463 | $0.00 | 5,537.0000 | 54,337,901 | 44.63% | 0.01% |
| Aug. 26, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5407 | $9.57 | 34,462.0000 | 54,337,901 | 18.61% | 0.01% |
| Aug. 26, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 4463 | $1.86 | 29,055.0000 | 54,337,901 | 18.15% | 0.01% |
| Aug. 26, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5407 | $0.00 | 106,259.0000 | 54,337,901 | 4.84% | 0.01% |
| Aug. 26, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 9870 | $25.01 | 24,592.0000 | 54,337,901 | 28.64% | 0.02% |
| Aug. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 5460 | $21.39 | 24,892.0000 | 54,337,901 | 17.99% | 0.01% |
| Aug. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 30,352.0000 | 54,337,901 | 23.42% | 0.01% |
| Aug. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 300 | $22.18 | 24,592.0000 | 54,337,901 | 1.21% | 0.00% |
| Aug. 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 82,786.0000 | 54,337,901 | 6.51% | 0.01% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 14,000.0000 | 54,337,901 | 12.50% | 0.00% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 3750 | $0.00 | 41,250.0000 | 54,337,901 | 8.33% | 0.01% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 23,762.0000 | 54,337,901 | 9.19% | 0.00% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 27,512.0000 | 54,337,901 | 15.78% | 0.01% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 2920 | $20.67 | 24,592.0000 | 54,337,901 | 10.61% | 0.01% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 21,762.0000 | 54,337,901 | 9.70% | 0.00% |
| July 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 11,545.0000 | 54,337,901 | 14.28% | 0.00% |
| July 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 801 | $21.57 | 19,838.0000 | 54,337,901 | 3.88% | 0.00% |
| July 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 5760 | $0.00 | 88,546.0000 | 54,337,901 | 6.11% | 0.01% |
| July 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 5760 | $1.86 | 25,598.0000 | 54,337,901 | 29.04% | 0.01% |
| July 1, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 4959 | $20.68 | 20,639.0000 | 54,337,901 | 19.37% | 0.01% |
| June 13, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1864 | $1.86 | 21,702.0000 | 54,337,901 | 9.40% | 0.00% |
| June 13, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 1864 | $0.00 | 94,306.0000 | 54,337,901 | 1.94% | 0.00% |
| June 13, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 1864 | $17.02 | 19,838.0000 | 54,337,901 | 8.59% | 0.00% |
| June 12, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 1900 | $0.00 | 96,170.0000 | 54,337,901 | 1.94% | 0.00% |
| June 12, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 1900 | $17.01 | 19,838.0000 | 54,337,901 | 8.74% | 0.00% |
| June 12, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1900 | $1.86 | 21,738.0000 | 54,337,901 | 9.58% | 0.00% |
| June 5, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 400 | $0.00 | 98,070.0000 | 54,337,901 | 0.41% | 0.00% |
| June 5, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 400 | $1.86 | 20,238.0000 | 54,337,901 | 2.02% | 0.00% |
| June 5, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 400 | $17.00 | 19,838.0000 | 54,337,901 | 1.98% | 0.00% |
| June 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1596 | $1.86 | 21,434.0000 | 54,337,901 | 8.05% | 0.00% |
| June 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Employee Stock Option (right to buy) | 1596 | $0.00 | 98,470.0000 | 54,337,901 | 1.59% | 0.00% |
| June 3, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 1596 | $17.01 | 19,838.0000 | 54,337,901 | 7.45% | 0.00% |
| April 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 16,000.0000 | 54,337,901 | 11.11% | 0.00% |
| April 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 21,351.0000 | 54,337,901 | 10.34% | 0.00% |
| April 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 19,351.0000 | 54,337,901 | 11.04% | 0.00% |
| April 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 1513 | $12.04 | 19,838.0000 | 54,337,901 | 7.09% | 0.00% |
| April 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 13,469.0000 | 54,337,901 | 12.50% | 0.00% |
| Feb. 13, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 54,337,901 | 9999.99% | 0.28% |
| Feb. 13, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | A | Restricted Stock Units | 45000 | $0.00 | 45,000.0000 | 54,337,901 | 9999.99% | 0.08% |
| Jan. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 1760 | $7.99 | 17,427.0000 | 54,337,901 | 9.17% | 0.00% |
| Jan. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 17,187.0000 | 54,337,901 | 12.61% | 0.00% |
| Jan. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 18,000.0000 | 54,337,901 | 10.00% | 0.00% |
| Jan. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 15,393.0000 | 54,337,901 | 11.11% | 0.00% |
| Jan. 30, 2024 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 19,187.0000 | 54,337,901 | 11.64% | 0.00% |
| Oct. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 2000 | $0.00 | 16,495.0000 | 48,607,990 | 13.80% | 0.00% |
| Oct. 31, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | S | Common Stock | 1232 | $5.20 | 15,263.0000 | 48,607,990 | 7.47% | 0.00% |
| Oct. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Common Stock | 1924 | $0.00 | 14,495.0000 | 48,607,990 | 15.31% | 0.00% |
| Oct. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 2000 | $0.00 | 20,000.0000 | 48,607,990 | 9.09% | 0.00% |
| Oct. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | Chief Legal Officer | M | Restricted Stock Units | 1924 | $0.00 | 17,317.0000 | 48,607,990 | 10.00% | 0.00% |
| July 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Common Stock | 2000 | $0.00 | 13,964.0000 | 48,607,990 | 16.72% | 0.00% |
| July 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Restricted Stock Units | 2000 | $0.00 | 22,000.0000 | 48,607,990 | 8.33% | 0.00% |
| July 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Restricted Stock Units | 1924 | $0.00 | 19,241.0000 | 48,607,990 | 9.09% | 0.00% |
| July 31, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | S | Common Stock | 1420 | $9.65 | 12,544.0000 | 48,607,990 | 10.17% | 0.00% |
| July 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Common Stock | 1924 | $0.00 | 11,964.0000 | 48,607,990 | 19.16% | 0.00% |
| April 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Common Stock | 1924 | $0.00 | 10,722.0000 | 48,607,990 | 21.87% | 0.00% |
| May 1, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | S | Common Stock | 682 | $9.88 | 10,040.0000 | 48,607,990 | 6.36% | 0.00% |
| April 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Restricted Stock Units | 1924 | $0.00 | 21,165.0000 | 48,607,990 | 8.33% | 0.00% |
| Feb. 14, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | A | Restricted Stock Units | 24000 | $0.00 | 24,000.0000 | 48,607,990 | 9999.99% | 0.05% |
| Feb. 14, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | A | Employee Stock Option (right to buy) | 88900 | $0.00 | 88,900.0000 | 48,607,990 | 9999.99% | 0.18% |
| Jan. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | S | Common Stock | 848 | $11.78 | 7,261.0000 | 48,607,990 | 10.46% | 0.00% |
| Jan. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Common Stock | 1924 | $0.00 | 8,109.0000 | 48,607,990 | 31.11% | 0.00% |
| Jan. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Ring Christine | General Counsel | M | Restricted Stock Units | 1924 | $0.00 | 23,089.0000 | 48,607,990 | 7.69% | 0.00% |